Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cray Research was a pioneering supercomputing company founded by Seymour Cray in 1972, renowned for developing the world's fastest high-performance computing (HPC) systems. While primarily a technology firm, its systems became foundational to the life sciences industry, providing the computational power necessary for the early Human Genome Project, complex protein folding simulations, and molecular modeling in drug discovery. The company's legacy continues through its acquisition by Hewlett Packard Enterprise (HPE), where Cray technology remains a critical infrastructure component for genomic research, precision medicine, and large-scale biological data analysis. Today, Cray-branded supercomputers are utilized by major pharmaceutical companies and research institutions to accelerate the identification of therapeutic targets and the simulation of drug-target interactions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cray Research.